<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 18-year-old man with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> after stem-cell transplantation developed breakthrough <z:e sem="disease" ids="C0343939" disease_type="Disease or Syndrome" abbrv="">trichosporonosis</z:e> while being administered <z:chebi fb="0" ids="10023">voriconazole</z:chebi>, a broad-spectrum <z:chebi fb="0" ids="38597">triazole</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Importantly, Trichosporon was detected soon after <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> by a screening serum polymerase chain reaction test, but not by blood culture </plain></SENT>
<SENT sid="2" pm="."><plain>This case illustrates that the serum polymerase chain reaction assay might be effective for early detection of <z:e sem="disease" ids="C0085082" disease_type="Disease or Syndrome" abbrv="">fungemia</z:e> in immunocompromised patients, including recipients of stem-cell transplants undergoing prophylactic antifungal therapy using <z:chebi fb="0" ids="10023">voriconazole</z:chebi>, which cannot be assumed to always provide complete protection against <z:e sem="disease" ids="C1096022" disease_type="Disease or Syndrome" abbrv="">Trichosporon infection</z:e> </plain></SENT>
</text></document>